Invesco Biotechnology & Genome ETF Rating → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free PBE Stock Alerts $60.39 +0.54 (+0.90%) (As of 04/26/2024 08:53 PM ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy2.70Holdings in PBE have an aggregate rating of Moderate Buy based on 326 analyst ratings issued in the past year covering 29 companies (97.2% of the portfolio).PBE Aggregate Price Target$82.8937.26% UpsideHigh Prediction$107.88Average Prediction$82.89Low Prediction$59.35Holdings in PBE have an aggregate price target of $82.89 and a range of $59.35 to $107.88 covering 29 companies (97.2% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 29 PBE Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.55%NBIXNeurocrine Biosciences$135.99-1.3%5 of 5 stars2.74$142.38 4.7%23Upcoming EarningsShort Interest ↓5.08%AMGNAmgen$269.98+0.2%5 of 5 stars2.53$297.40 10.2%19Upcoming Earnings5.05%VRTXVertex Pharmaceuticals$397.48-0.1%4 of 5 stars2.48$429.45 8.0%23Upcoming Earnings5.03%REGNRegeneron Pharmaceuticals$883.20-0.8%5 of 5 stars2.70$977.77 10.7%20Upcoming Earnings4.95%BMRNBioMarin Pharmaceutical$80.91-1.5%5 of 5 stars2.63$107.50 32.9%19Analyst ReportShort Interest ↑Analyst Revision4.93%BIIBBiogen$208.90+3.2%5 of 5 stars2.67$293.88 40.7%27Earnings ReportShort Interest ↓Analyst Revision4.84%GILDGilead Sciences$65.42+0.2%5 of 5 stars2.35$83.87 28.2%17Earnings ReportDividend AnnouncementAnalyst ReportShort Interest ↓Analyst Revision4.76%TECHBio-Techne$64.06+2.2%5 of 5 stars2.80$83.90 31.0%10Upcoming Earnings3.38%MNKDMannKind$4.23+1.2%2 of 5 stars3.00$8.00 89.1%3News Coverage3.32%EXELExelixis$23.70+0.7%5 of 5 stars2.60$26.29 10.9%15Upcoming EarningsShort Interest ↑Analyst Revision3.26%COLLCollegium Pharmaceutical$36.42+1.6%2 of 5 stars2.60$39.00 7.1%5Upcoming Earnings3.21%UTHRUnited Therapeutics$233.85-0.9%5 of 5 stars2.89$294.25 25.8%9Upcoming Earnings3.11%HALOHalozyme Therapeutics$38.57+0.3%5 of 5 stars2.86$53.29 38.2%73.10%CPRXCatalyst Pharmaceuticals$14.89+1.4%5 of 5 stars3.00$26.43 77.5%5Analyst Revision3.06%TGTXTG Therapeutics$13.47-3.2%4 of 5 stars2.83$29.00 115.3%6Upcoming Earnings2.90%BPMCBlueprint Medicines$93.00+2.5%1 of 5 stars2.50$91.57 -1.5%14Upcoming EarningsAnalyst ReportNews CoverageGap Up2.86%PTCTPTC Therapeutics$28.57+12.1%3 of 5 stars1.85$33.53 17.4%13Earnings Report2.85%ITCIIntra-Cellular Therapies$73.26+1.6%4 of 5 stars2.90$90.17 23.1%10Upcoming EarningsAnalyst Revision2.75%IONSIonis Pharmaceuticals$41.59-0.6%4 of 5 stars2.69$56.08 34.8%13Positive News2.74%CLDXCelldex Therapeutics$36.30+0.1%0 of 5 stars2.80$66.00 81.8%5Upcoming Earnings2.68%VCELVericel$46.05+1.3%0 of 5 stars3.00$46.40 0.8%62.65%DVAXDynavax Technologies$11.21+0.4%4 of 5 stars2.75$25.00 123.0%4Analyst Downgrade2.42%RGENRepligen$166.58+0.6%4 of 5 stars2.89$196.70 18.1%9Upcoming EarningsPositive News2.41%XENEXenon Pharmaceuticals$40.50+1.0%3 of 5 stars3.00$59.44 46.8%9Positive News2.27%VCYTVeracyte$19.31-0.9%4 of 5 stars2.60$29.00 50.2%5Upcoming Earnings2.23%MYGNMyriad Genetics$18.18+1.1%4 of 5 stars2.33$23.17 27.4%6Upcoming Earnings2.16%FOLDAmicus Therapeutics$10.28+1.1%4 of 5 stars3.00$20.00 94.6%3Positive News1.91%ACADACADIA Pharmaceuticals$16.71+2.5%4 of 5 stars2.80$32.13 92.3%151.70%EYPTEyePoint Pharmaceuticals$16.75+3.7%3 of 5 stars3.00$34.00 103.0%6Upcoming EarningsPositive News This page (NYSEARCA:PBE) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
